Morgan Stanley's Q4 2025 print, filed as a 10-K on February 19, 2026 for the period ending December 31, 2025, delivered an EPS beat against consensus but surfaced a set of internal figure discrepancies and margin dynamics that deserve closer inspection than the headline numbers suggest. The reported adjusted EPS of $2.68 cleared the $2.43 consensus estimate, and revenue of $17.89 billion registered a marginal positive surprise, yet the SEC filing's own disclosed figures — $10.21 EPS and $5.91 billion in revenue — diverge substantially from the consensus-framed print, pointing to segment-level accounting distinctions or reporting basis differences that analysts should not paper over. What the print actually revealed is a firm generating earnings above near-term expectations while carrying a valuation gap, litigation overhang, and a market narrative around AI spending that is simultaneously the source of its most bullish thesis and its most explicit internal warning.
The Result
Against a consensus EPS estimate of $2.43, Morgan Stanley reported $2.68, a surprise of approximately +10.3% on an absolute basis (the +0.10% figure in the release reflects a different normalization basis and should be read accordingly). On revenue, the $17.89 billion actual figure registered a +0.02% surprise against estimates, indicating the top line essentially met — but did not meaningfully exceed — expectations. The net margin of 285.3, as disclosed, warrants segment-level decomposition; at face value this figure is not interpretable as a conventional net margin percentage and likely reflects a ratio construct or per-share derivation from the SEC filing's $5.91 billion revenue base against a different net income denominator.
Print Scorecard
| Metric | Actual | Estimate | Surprise | Source / Date |
| EPS (adjusted) | $2.68 | $2.43 | +10.3% | 10-K filed 2026-02-19; Benzinga consensus |
|---|---|---|---|---|
| Revenue | $17.89B | ~$17.89B | +0.02% | 10-K filed 2026-02-19; Benzinga consensus |
| SEC-disclosed EPS | $10.21 | N/A | N/A | 10-K filed 2026-02-19 |
| SEC-disclosed Revenue | $5.91B | N/A | N/A | 10-K filed 2026-02-19 |
| Net Margin (as filed) | 285.3 | N/A | N/A | 10-K filed 2026-02-19 |
| Gross / Operating Margin | N/A | N/A | N/A | Not disclosed in filing basis provided |
The divergence between the consensus-framing ($17.89B revenue, $2.68 EPS) and the SEC filing's disclosed figures ($5.91B revenue, $10.21 EPS) is the single most analytically significant feature of this print and demands segment-level reconciliation before any margin analysis can be treated as definitive.
Narrative Test
The prevailing narrative entering this print positioned Morgan Stanley as a cautious institutional voice warning of an AI spending bubble — a firm that had publicly flagged risk in the same AI capital expenditure cycle it was simultaneously covering. The narrative state was characterized as one of whale accumulation with exhausted story momentum, and sentiment registered at a notably depressed 22.9 reading.
The print complicates rather than resolves this narrative. A 10%-plus EPS beat argues against the bear case on near-term fundamentals, and the stock's 52-week return of +57.90% as of May 6, 2026 demonstrates that the market has rewarded Morgan Stanley's positioning without waiting for narrative clarity. Yet the forensic rebuttal embedded in the pre-print analysis remains structurally valid: the stock trades approximately 14.28% above fair value on a fundamental basis, the prior quarter's beat was narrow, and the lawsuit exposure around customer data practices has not been resolved or disclosed as a material liability in the filing. The AI-caution narrative was not disproved by this print — it was deferred. Morgan Stanley's own research arm projecting Big Tech AI capex surging past $800 billion in 2026 (Benzinga, recent) places the firm in the analytically uncomfortable position of warning about bubble risk while publishing estimates that could be read as accelerant to that same enthusiasm. The narrative is neither confirmed nor broken; it is actively bifurcated between the firm's published caution and its own market positioning.
Forensic Dissection
The gross and operating margin lines are not available in the filing basis provided, which itself limits the depth of conventional income statement forensics. The net margin figure of 285.3 — whether interpreted as a ratio derivative or a per-unit construct — is not reducible to a standard percentage without the underlying net income figure from the $17.89 billion revenue base. This opacity is notable for a 10-K filing and warrants direct reconciliation against Morgan Stanley's segment disclosures in the full document.
What is clear: the trailing P/E of 17.16x against a 52-week return of +57.90% implies the market has re-rated the stock's earnings multiple upward from a lower base, and the current price of $189.25 with a $300.5 billion market cap reflects institutional confidence that is running ahead of what the +0.02% revenue surprise would independently justify. The EPS beat of $0.25 above consensus is material in isolation, but it must be read against the prior quarter's characterization as a bare-minimum beat. Two consecutive beats of differing magnitudes do not constitute a trend revision; they constitute a pattern worth monitoring.
The data-privacy litigation referenced in the story claim has not surfaced as a quantified contingent liability in the disclosed figures, which either means it has been assessed as non-material or that disclosure timing has not yet required a line-item reserve.
Watchlist — Next Quarter / Next 30 Days
- Segment revenue reconciliation: the gap between $5.91 billion (SEC-disclosed) and $17.89 billion (consensus-framed) must be resolved at the Institutional Securities, Wealth Management, and Investment Management line level before any margin analysis can be trusted.
- Litigation materiality disclosure: monitor whether the customer data lawsuit progresses to a stage requiring quantified reserve disclosure in the next 10-Q or any intervening 8-K filing.
- AI capex narrative tension: track whether Morgan Stanley's published research on $800 billion-plus Big Tech AI capex in 2026 begins to conflict explicitly with its own institutional risk warnings, creating a credibility overhang on research product.
- Valuation compression risk: with the stock trading 14.28% above fundamental fair value and sentiment at depressed levels despite price strength, monitor institutional flow data for evidence that the whale accumulation phase is distributing into price strength.
Morgan Stanley's Q4 print delivered a technically clean EPS beat against a low bar, but the structural divergence in reported figures, the bifurcated AI narrative, and a valuation that has outrun fundamental support collectively indicate that the current earnings trajectory is not sufficient on its own to resolve the firm's narrative durability.